Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Zhila Maghbooli, Mohammad Ali Sahraian, Saeidreza Jamalimoghadamsiahkali, Asma Asadi, Azadeh Zarei, Abolfazl Zendehdel, Tarlan Varzandi, Sara Mohammadnabi, Neda Alijani, Mehrdad Karimi, Arash Shirvani, Michael F. Holick
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Internal medicineLymphocyteNeutrophil to lymphocyte ratioRandomized controlled trial2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Multicenter studySurrogate endpointDiseaseGastroenterologyImmunologyPathologyOutbreakInfectious disease (medical specialty)Vitamin D Research StudiesVitamin C and Antioxidants ResearchCOVID-19 Clinical Research Studies